欧洲肿瘤内科学会（ESMO）-欧洲妇科肿瘤学会（ESGO）-欧洲放射肿瘤学会（ESTRO）子宫内膜癌共识会议：诊断、治疗与随访
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.
作者信息
Colombo Nicoletta, Creutzberg Carien, Amant Frederic, Bosse Tjalling, González-Martín Antonio, Ledermann Jonathan, Marth Christian, Nout Remi, Querleu Denis, Mirza Mansoor Raza, Sessa Cristiana
机构信息
Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy.
Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
出版信息
Radiother Oncol. 2015 Dec;117(3):559-81. doi: 10.1016/j.radonc.2015.11.013. Epub 2015 Dec 9.
The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: Prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.
欧洲肿瘤内科学会（ESMO）、欧洲放射治疗与肿瘤学会（ESTRO）和欧洲妇科肿瘤学会（ESGO）关于子宫内膜癌的首次联合共识会议于2014年12月11日至13日在意大利米兰举行，由40位子宫内膜癌管理领域的顶尖专家组成的多学科小组参与。会议前，专家小组就子宫内膜癌准备了三个与以下四个领域相关的临床问题：预防与筛查、手术、辅助治疗以及晚期和复发性疾病。专家们确定的所有相关科学文献均提前进行了审查。在共识会议期间，小组针对每个具体问题制定了建议并达成了共识。本文详细介绍了本次共识会议的结果以及支持每项建议的证据总结。所有参与者均已批准这篇最终文章。
Zotero 插件